SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-18-027157
Filing Date
2018-05-10
Accepted
2018-05-10 16:29:25
Documents
99
Period of Report
2018-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q tv492654_10q.htm 10-Q 900246
2 EXHIBIT 31.1 tv492654_ex31-1.htm EX-31.1 10040
3 EXHIBIT 31.2 tv492654_ex31-2.htm EX-31.2 10088
4 EXHIBIT 32.1 tv492654_ex32-1.htm EX-32.1 4438
5 EXHIBIT 32.2 tv492654_ex32-2.htm EX-32.2 4239
  Complete submission text file 0001144204-18-027157.txt   10373042

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT fbio-20180331.xml EX-101.INS 2899873
7 XBRL TAXONOMY EXTENSION SCHEMA fbio-20180331.xsd EX-101.SCH 105430
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE fbio-20180331_cal.xml EX-101.CAL 65842
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE fbio-20180331_def.xml EX-101.DEF 634946
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE fbio-20180331_lab.xml EX-101.LAB 654697
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE fbio-20180331_pre.xml EX-101.PRE 684987
Mailing Address 2 GANSEVOORT STREET 9TH FLOOR NEW YORK NY 10014
Business Address 2 GANSEVOORT STREET 9TH FLOOR NEW YORK NY 10014 781-652-4500
Fortress Biotech, Inc. (Filer) CIK: 0001429260 (see all company filings)

IRS No.: 205157386 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35366 | Film No.: 18822976
SIC: 2834 Pharmaceutical Preparations